New study tests smaller liver surgery for tough bile duct cancers

NCT ID NCT07149558

Not yet recruiting Knowledge-focused Sponsor: Yongjun Chen Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at a type of liver surgery called volume-restricted resection for patients with a rare bile duct cancer (perihilar cholangiocarcinoma) whose liver is too small after standard surgery. Researchers will follow 300 patients who get this surgery or non-surgical care to see if it improves survival and safety compared to usual treatment. It is an observational study, meaning patients receive their normal care, and data is collected for comparison.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could show that a less extensive liver surgery is safe and improves survival for patients with this bile duct cancer who currently have few options.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by patient selection. The approach is still experimental and may not improve outcomes or could carry higher risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA, HILAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hilar cholangiocarcinoma perihilar intrahepatic cholangiocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOLANGIOCARCINOMA, HILAR

More trials for these conditions

Other studies related to the condition(s) this trial covers.